All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
OYST / Oyster Point Pharma Inc
|
|
|
|
|
|
|
|
SENS / Senseonics Holdings, Inc.
|
|
|
|
|
|
|
|
SBBP / Strongbridge Biopharma plc
|
|
|
|
|
|
|
|
EYRYY / Erytech Pharma
|
|
|
|
|
|
|
|
SPT / Sprout Social, Inc.
|
|
|
|
|
|
|
|
GLYC / GlycoMimetics, Inc.
|
|
|
|
|
|
|
|
MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
MILE / Metromile Inc
|
|
|
|
|
|
|
|
OPEN / Opendoor Technologies Inc.
|
|
|
|
|
|
|
|
TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
VTGN / Vistagen Therapeutics, Inc.
|
|
|
|
|
|
|
|
IVA / Inventiva S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
BDTX / Black Diamond Therapeutics, Inc.
|
|
|
|
|
|
|
|
NET / Cloudflare, Inc.
|
|
|
|
|
|
|
|
EAR / Eargo, Inc.
|
|
|
|
|
|
|
|
TRVN / Trevena, Inc.
|
|
|
|
|
|
|
|
GRTX / Galera Therapeutics, Inc.
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
LUMO / Lumos Pharma, Inc.
|
|
|
|
|
|
|
|
SVRA / Savara Inc.
|
|
|
|
|
|
|
|
AKUS / Akouos Inc
|
|
|
|
|
|
|
|
BE / Bloom Energy Corporation
|
|
|
|
|
|
|
|
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
|
|
|
|
|
|
|
|
MEIP / MEI Pharma, Inc.
|
|
|
|
|
|
|
|
LQDA / Liquidia Corporation
|
|
|
|
|
|
|
|
PANW / Palo Alto Networks, Inc.
|
|
|
|
|
|
|
|
STSA / Satsuma Pharmaceuticals Inc
|
|
|
|
|
|
|
|
PLTR / Palantir Technologies Inc.
|
|
|
|
|
|
|
|
MTCR / Metacrine Inc
|
|
|
|
|
|
|
|
ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
CSPR / Casper Sleep Inc
|
|
|
|
|
|
|
|
PHAS / PhaseBio Pharmaceuticals Inc
|
|
|
|
|
|
|
|
DZSI / DZS Inc.
|
|
|
|
|
|
|
|
GNCA / Genocea Biosciences Inc
|
|
|
|
|
|
|
|
AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
UPST / Upstart Holdings, Inc.
|
|
|
|
|
|
|
|
OBSV / ObsEva SA.
|
|
|
|
|
|
|
|
TCON / TRACON Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
ANNX / Annexon, Inc.
|
|
|
|
|
|
|
|
GERN / Geron Corporation
|
|
|
|
|
|
|
|
MRKR / Marker Therapeutics, Inc.
|
|
|
|
|
|
|
|
TPST / Tempest Therapeutics, Inc.
|
|
|
|
|
|
|
|
AVEO / AVEO Pharmaceuticals Inc
|
|
|
|
|
|
|
|
COUR / Coursera, Inc.
|
|
|
|
|
|
|
|
RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
INZY / Inozyme Pharma, Inc.
|
|
|
|
|
|
|
|
DM / Desktop Metal, Inc.
|
|
|
|
|
|
|
|
RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SYBX / Synlogic, Inc.
|
|
|
|
|
|
|
|
CSBR / Champions Oncology, Inc.
|
|
|
|
|
|
|
|
CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|
TRVI / Trevi Therapeutics, Inc.
|
|
|
|
|
|
|
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
NKTX / Nkarta, Inc.
|
|
|
|
|
|
|
|
LXRX / Lexicon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|